Lucite embedment with drug vial commemorating a study of a treatment for solid tumor cancer.
(21ADH006)Lucite embedment with drug vial commemorating a study of a treatment for solid tumor cancer.
(21ADH006)Lucite commemorative celebrating a development and commercialization agreement between Takeda and Arrowhead Pharmaceuticals.
(21ALJ357)Financial tombstone marking the successful placement by Siegfried Holding of a senior bond. The Swiss firm provides development and production services to the pharmaceutical and life sciences sectors.
(21LSS233)Crystal deal toy commemorating a follow-on offering by electroCore, a bioelectronic medicine company.
(21AJH117)Crystal deal toy commemorating a private placement by X4 Pharmaceuticals.
(21ALJ247)Crystal deal toy commemorating Series A financing for Interius BioTherapeutics, a preclinical stage gene therapy firm.
(21AKL266)Crystal commemorative marking the initial public offering of Australian biotech firm Chimeric Therapeutics. The firm is developing a class of cell therapy drugs for the treatment of cancer.
(21ALJ210)Lucite tombstone commemorating crossover funding for AbSci, a Vancouver, Washington-based biotech firm.
(21ALJ163)Crystal deal tombstone celebrating the initial public offering of Arctic Bioscience. The Norwegian biotech firm makes use of bioactive marine compounds, including herring roe extracts.
(21LJW055)